ArticleFrontiers in endocrinology2025
The effect of type 2 diabetes on periapical osteoclast-related factors during axial tooth movement.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To explore the impact of type 2 diabetes on tooth axial elongation and its relationship with osteoclast-related factors. Materials and methods: We established an unopposed molars model of type 2 diabetic mice, and recorded changes in mandibular bone mineral density (BMD) using micro-CT. Changes in the cells and fibers were observed by Hematoxylin and Eosin (HE) staining, Masson staining and Tartrate Resistant Acid Phosphatase (TRAP) activity assay of the right mandibles. The expression levels of osteopontin (OPN), receptor activator for nuclear factor-κ (RANK) and Receptor Activator of Nuclear Factor-κ B Ligand (RANKL) were observed using immunohistochemistry and RT-qPCR. Results: Micro-computed tomography (CT) analysis showed that tooth elongation and bone mineral density (BMD) in both groups increased over time but were consistently lower in diabetic mice compared to controls. Histological staining showed that diabetic mice had more osteoclasts and bone resorption, with sparser collagen. Immunohistochemistry and RT-qPCR showed that the expression levels of osteopontin (OPN), receptor activator for nuclear factor-κ (RANK), and receptor activator of nuclear factor-κ B ligand (RANKL) in both groups increased over time but were higher in diabetic mice compared to controls. Conclusions: Type 2 diabetes may slow down the axial elongation of teeth. The aggravate bone resorption based on the abnormal expression of RANK, RANKL, and OPN was a probable reason for the inhibition of alveolar bone remodeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.